Skip to main content

NuGen Raises $7.5M in Series C

NEW YORK, Aug. 20 (GenomeWeb News) - NuGen Technologies of San Carlos, Calif., has raised $7.5 million in a Series C financing round, the company said Tuesday.


The financing round was led by individual investors, including William Rutter, co-founder of Chiron; George Rathmann, founder of Amgen and former CEO of Hyseq; and James Wilson, former president of Syntex, Neurex and LifeScan. Sutter Hill Ventures, of Palo Alto, Calif, as well as current investors Radius Venture Partners, The Band of Angels Fund, and MedCapital Ventures.


As a result of the financing, Rutter will join the company's board of directors.


The company , which makes nucleic acid and protein amplification and detection systems, said the proceeds of the financing would be used to further develop its infrastructure and its products.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.